Clinical Trial Update: A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the effect of Maridebart Cafraglutide on insulin sensitivity and beta-cell function in adults with Type 2 diabetes mellitus;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: RECRUITING